Ibrain（OA期刊）（国际刊号） 知网目次

期刊简介

《Ibrain》期刊已被查看： 次

更新频次

单位占比

一作占比

投稿指南

1、该刊只有国际刊号。

2、投稿方式：在线投稿。

3、刊内网址：（202401期）

https://onlinelibrary.wiley.com/journal/27692795

4、投稿系统：https://mc.manuscriptcentral.com/ibra

5、主办单位网址：

http://www.zmuhospital.com/Article/Class-334.html

（遵义医科大学附属医院）

6、刊内邮箱：Ibrain@idragon.org.cn

7、官网电话：0851-28608507

8、期刊刊期：季刊，逢季末月出版。

9、微信公众号：遵义医科大学附属医院（ZYykdxffyy）

2024年5月15日星期三

《Ibrain》投稿指南

【官网信息】

Ibrain

Author Guidelines

1. SUBMISSION

Authors should kindly note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/ibra.

Click here for more details on how to use ScholarOne.

Data protection:

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.

Preprint policy:

Please find the Wiley preprint policy here.

Ibrain will consider articles previously available as preprints. Authors are requested to update any pre-publication versions with a link to the final published article. Authors may also post the final published version of the article immediately after publication.

For help with submissions, please contact: Ibrain@idragon.org.cn

2. AIMS AND SCOPE

Ibrain is an international and open access journal in the field of neuroscience. The journal publishes the advanced research about brain function, brain network, brain structure and brain imaging, and provides a communication platform about basic & translational science and clinical practice for neuroscientists. Ibrain welcomes submissions all over the world that will benefit the development of neuroscience.

Ibrain is interested in the topics including but not limited to clinical medicine, molecule diagnostics, epigenetics/genetics, cell biology, drug discovery, evolutionary medicine, nanotechnology or artificial intelligence. The journal is focused on clinical and experimental advances that provide the disease characteristics, pathogenic mechanism or medical techniques.

Topics of interest include, but are not limited to:

Cellular and molecular neuroscience

Regeneration and plasticity

Development and stem cells

Cognition and psychiatric disorders

Neurodegeneration and repair

Neurodegenerative diseases

Stroke

Brain injury

Spinal cord injury

Cerebral ischemia

Brain tumor

Nerve injury

Head injury

Neural circuit

Neural technology

Neuropathy

Cerebral ischemia and hypoxia

Head and face disease

Neuralgia

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

Original article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make significant contribution to the scientific knowledge in neuroscience areas. Typically, the research will provide insight into an as yet unknown mechanism or poorly understood process, constitute a highly significant contribution to our understanding of neuroscience, and be of general interest to the neuroscience community. Research articles are typically 6000 words in length, with up to 12 figures and tables in total, and no limitation on the number of references.

Reviews, including systematic reviews and meta-analyses, are typically written by leading experts in the filed within the journal’s scope. Reviews papers help specialists to keep up with the current state of knowledge in a specific research area and provide informative message for non-specialists. Reviews aim to be a critical and concise overview of the most recent advances in a specific research field. Reviews will typically be no limitation on words in length, with up to 8 figures and tables in total, and no limitation on the number of references.

Comments discuss published findings and ideas from a personal viewpoint. They are more forward looking and /or speculative than Reviews. Comments can be submitted either by the invitations from the Editors or by the authors themselves. Both types will undergo the peer-review process prior to acceptance. Comments are typically 3000 words in length, with up to 4 figures and tables in total and no more than 70 references.

Case reports emphasize all aspects of clinical neuroscience. They should describe: (a) unique cases that may represent a previously undescribed condition; (b) unexpected association of two or more diseases; (c) adverse or unexpected treatment response; (d) any other clinical observation based upon well-documented cases that provides important new information; or (e) a new or revised clinical technique or procedure.

Letter provides the rapid and concise report of a novel discovery that is brief in nature and should be of general interest to the field of neuroscience. Letters are typically 1200 words in length excluding, references, figures and tables, with up to 1 figures and tables in total, and no more than 10 references.

Methods are news-style reports, and are published a few times a year to review techniques and technologies in fast-moving fields of research. For further information, contact  Ibrain@idragon.org.cn.

4. PREPARING THE SUBMISSION

Cover Letters

Authors may include recommended or non-recommended reviewers in the cover letter. Cover letters are not mandatory; however, they may be supplied at the author’s discretion.

Parts of the Manuscript

The manuscript should be submitted in separate files: main text file; figures.

Main Text File

The text file should be presented in the following order:

A short informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);

A short running title of less than 40 characters;

The full names of the authors;

The author's institutional affiliations where the work was conducted, with  a footnote for the author’s present address if different from where the work was conducted;

Abstract and keywords;

Main text;

Ethical statement

Acknowledgments;

Conflict of interest

Funding

Transparency statement

Authors' contribution

References;

Tables (each table complete with title and footnotes);

Figure legends;

Appendices (if relevant).

Figures and supporting information should be supplied as separate files.

For the benefit of the reviewers and editors, please include line numbers in your main text files.

Abstract

Please provide an abstract of 250 words containing the major keywords summarizing the article.

Keywords

Please provide three to six keywords.

Main Text

The journal uses British/US spelling; however, authors may submit using either option, as spelling of accepted papers is converted during the production process.

Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter

……

更多详情：

https://onlinelibrary.wiley.com/page/journal/27692795/homepage/author-guidelines

上一篇：赣南医学院学报下一篇：语言治理学刊（集刊）（不收版面费审稿费）